Your session is about to expire
← Back to Search
Adderall for ADHD with Risk of Substance Abuse
Study Summary
This trial will study the effects of a medication used to treat ADHD on the brain reward system in order to better understand the potential impact of the medication on people who are at risk for substance abuse.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your mother consumed alcohol or drugs during pregnancy, which may have affected your development.I have vision problems that could affect my ability to perform tasks.I am a young person with Conduct Disorder or severe Oppositional Defiant Disorder plus two symptoms of CD.I have a major psychiatric disorder or have had suicidal thoughts or attempts.I have had a head injury in the past.I am in the early stages of puberty.I can communicate well in English.You have metal in your body that cannot be taken out.I do not have any major neurological or medical illnesses.
- Group 1: Adderall
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential risks exist when utilizing Adderall?
"According to our team's assessment, Adderall has a safety rating of 3 due its Phase 4 trial status which is considered the final step prior to FDA approval."
Who is eligible to join in this medical experiment?
"This research study is seeking 44 pre-pubertal children, age 7 to 12, who have been diagnosed with conduct disorder. The eligibility requirements for participants include: signed consent/assent of parent or guardian; evidence of ADHD as determined by parent interview and scores on the Attention Deficit Hyperactivity Disorder Rating Scale-5 that are 1.5 standard deviations higher than average age/sex norms; diagnosis of either Conduct Disorder (CD) or Oppositional Defiant Disorder (ODD) plus two additional symptoms commonly associated with CD."
How many participants have been accepted for this medical experiment?
"Affirmative. Clinicaltrials.gov states that this clinical trial is still accepting patients and has been since November 5th, 2019. The most recent edition was made on May 16th 2022 with the goal of recruiting 44 people from a single site."
Does this clinical trial accept those aged 55 and older?
"This medical trial is only open to those between the age of 7 and 12. There are 415 trials available for minors, while 824 studies focus on patients over 65 years old."
What other empirical research has been conducted on Adderall?
"Currently, 9 trials surrounding Adderall are taking place with 2 of these in their final Phase 3. 13 medical sites across the globe are investigating this medication with a concentration being located in Lexington, Kentucky."
Is this trial actively seeking participants?
"As per the clinicaltrials.gov records, this research is calling for participants as of now. The study was initially launched on November 5th 2019 and was recently updated on May 16th 2022."
Who else is applying?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger